GSK3050002: Clinical Trials

2 trials of GSK3050002, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1

Follow GSK3050002: new trials by email Literature Review of GSK3050002 trials Research Report on GSK3050002

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis
GSK3050002, Placebo - Autoimmune Diseases
Phase 1WithdrawnGlaxoSmithKline2018-06-012018-08-31
Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002
GSK3050002, Placebo - Colitis, Ulcerative
Phase 1CompletedGlaxoSmithKline492014-01-102018-07-24

Conditions studied

Arthritis, Psoriatic (1)  ·  Autoimmune Diseases (1)  ·  Colitis, Ulcerative (1)  ·  Psoriasis (1)

Sponsors

GlaxoSmithKline (2)

Countries

United Kingdom (2)

Results publications

PMID 32325480